AdaptHealth (AHCO) to Release Quarterly Earnings on Tuesday

AdaptHealth (NASDAQ:AHCO) is expected to be announcing its Q4 2025 results before the market opens on Tuesday, February 24th. Analysts expect the company to announce earnings of $0.34 per share and revenue of $832.5060 million for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Tuesday, February 24, 2026 at 8:30 AM ET.

AdaptHealth Stock Performance

Shares of AHCO opened at $10.20 on Tuesday. AdaptHealth has a one year low of $7.11 and a one year high of $11.63. The stock has a 50-day moving average of $10.25 and a 200-day moving average of $9.64. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.08 and a quick ratio of 0.86. The company has a market cap of $1.38 billion, a PE ratio of 18.55, a P/E/G ratio of 1.16 and a beta of 1.72.

Wall Street Analyst Weigh In

A number of research firms have weighed in on AHCO. Zacks Research raised shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Weiss Ratings raised AdaptHealth from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, January 30th. Wall Street Zen lowered AdaptHealth from a “strong-buy” rating to a “buy” rating in a report on Saturday. Finally, Canaccord Genuity Group increased their price target on AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $14.25.

Insider Buying and Selling at AdaptHealth

In other news, Director David Solomon Williams III sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, December 4th. The shares were sold at an average price of $9.43, for a total value of $47,150.00. Following the sale, the director owned 45,045 shares of the company’s stock, valued at $424,774.35. The trade was a 9.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.55% of the stock is owned by insiders.

Institutional Investors Weigh In On AdaptHealth

Institutional investors have recently made changes to their positions in the stock. Ieq Capital LLC raised its position in shares of AdaptHealth by 47.9% in the fourth quarter. Ieq Capital LLC now owns 15,856 shares of the company’s stock worth $158,000 after buying an additional 5,138 shares in the last quarter. EntryPoint Capital LLC increased its stake in AdaptHealth by 24.6% in the 4th quarter. EntryPoint Capital LLC now owns 15,919 shares of the company’s stock worth $159,000 after acquiring an additional 3,142 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of AdaptHealth by 34.3% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 28,422 shares of the company’s stock valued at $254,000 after acquiring an additional 7,266 shares in the last quarter. Vident Advisory LLC raised its holdings in shares of AdaptHealth by 17.9% in the 2nd quarter. Vident Advisory LLC now owns 17,737 shares of the company’s stock valued at $167,000 after acquiring an additional 2,694 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its holdings in shares of AdaptHealth by 53.9% during the second quarter. BNP Paribas Financial Markets now owns 28,159 shares of the company’s stock worth $266,000 after purchasing an additional 9,861 shares in the last quarter. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.